Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 56%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare's positive outlook is supported by its strategic investments in the USPI segment, which is characterized by faster growth and higher margins, leading to an anticipated improvement in return on invested capital (ROIC). The company's financial performance is expected to benefit from increased income from equity earnings and a favorable payer mix, alongside initiatives aimed at enhancing its cost structure. With strong demand and margin expansion projected, Tenet Healthcare is well-positioned to leverage its competitive advantages and capitalize on outpatient growth opportunities in the healthcare market.

Bears say

Tenet Healthcare's stock faces a negative outlook primarily due to anticipated headwinds from subsidy expirations, which are projected to impact revenues by $220 million in its Acute segment and $30 million in its USPI operations by 2026. Additionally, the potential loss of insurance coverage for 80-85% of affected individuals could lead to a decline in patient utilization, further exacerbating financial pressures. Despite previous non-recurring revenue boosts from Medicaid state payments, the company's valuation remains stagnant and disconnected from its underlying financial performance and ongoing deleveraging efforts.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 56% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.28, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.28, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.